Latest news and updates of Dubai property market and project reviews.
A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer - New York Times |
| Published: May 31, 2008, 9:52 pm |
|
dBTechnoA Drug Is Credited With Slight Gains for Patients Who Have Lung CancerNew York Times - 12 hours agoBy ANDREW POLLACK CHICAGO - The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers are reporting here this weekend.UPDATE: Erbitux, Avastin Combo No Benefit In Colon Cancer CNNMoney.comImClone's Erbitux Prolongs Life in Lung Cancer Study (Update3) BloombergReuters - U.S. News & World Report - eFluxMedia - Forbesall 431 news articles [ Full article ] |
 Blog link
|
No Comments...